Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsSUBCUTANEOUSStandard

AVTOZMA

TOCILIZUMAB-ANOH

Standard Dose
162MG/0.9ML
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Prescription
Summary

Approval overview AVTOZMA is listed in Drugs@FDA under application 761420 (BLA).

Marketing status: Prescription Active ingredient TOCILIZUMAB-ANOH Form and strength INJECTABLE;SUBCUTANEOUS - 162MG/0.9ML Sponsor CELLTRION INC Submission history Latest submission status date: 2026-01-14 00:00:00.

Structured Monograph

Clinical summary

Approval overview AVTOZMA is listed in Drugs@FDA under application 761420 (BLA). Marketing status: Prescription Active ingredient TOCILIZUMAB-ANOH Form and strength INJECTABLE;SUBCUTANEOUS - 162MG/0.9ML Sponsor CELLTRION INC Submission history Latest submission status date: 2026-01-14 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Prescription

Interaction Notes

  • No interaction notes stored yet.